Fact CheckerSign in

NCT06016478Completed

The Effect of 4 Weeks of L-Citrulline Supplementation on Macro- and Microvascular Function in Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 15 May 2025

Brief summary (registry, in English)

The purpose of this study is to examine the effect of 4 weeks of Citrulline supplementation on macro- and microvascular function during acute hyperglycemia in middle-aged and older adults with type 2 diabetes.

Status (registry)
Completed
Study type
Interventional
Enrollment
36 (actual)
First submitted
19 Aug 2023
Start date
1 May 2023
Primary completion date
1 Jul 2024
Lead sponsor
Texas Tech University
NCT number
NCT06016478

What you commit to

  • Study type: Interventional
  • Participants enrolled: 36
  • From 1 May 2023 to the primary completion date, 1 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of medications and/or any supplements that may affect outcome variables (such as arginine- or citrulline-containing supplements, nitrates, and nitroglycerin)
  • Recent changes in medications within 3 months

Other illness

  • Type 1 diabetes, severe cardiovascular/renal/pulmonary diseases

Age

  • \< 40 years of age and \> 65 years of age

Other

  • Body mass index ≥ 40 kg/m2
  • Systolic blood pressure ≥ 160 mmHg
  • Current smoking any tobacco use
  • More than 7 alcoholic drinks/week of consumption
  • Premenopausal women with an irregular menstrual cycle (oligomenorrhea) or pregnancy

Who the study is looking for

  • Middle-aged and older women and men between 40-75 years old
  • A physician diagnosed type 2 diabetes at least 3 months ago
  • Treated with an oral hypoglycemic medication
  • Body mass index \< 40 kg/m2
  • Systolic blood pressure \< 160 mmHg
  • Sedentary (defined as \< 120 min/week of exercise)
  • Not currently participating in exercise or dietary interventions for at least 2 months prior the present study and willing to abstain from participating in those strategies during the duration of this study.

Age in the registry: 40 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
TTU Kinesiology and Sport Management Building
Coordinator of this site? Confirm its status
LubbockUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.